Allogene Therapeutics
Sindy Mancuso is a Senior Associate Scientist at Allogene Therapeutics, having joined the company in November 2022. Previously, Sindy held positions as an Associate Scientist and a Research Associate at Adverum Biotechnologies, where responsibilities included evaluating upstream AAV process optimizations and maintaining cell culture and data analysis. Prior to that, Sindy worked as an Accessioning Technician at Exact Sciences, performing data entry and processing tissue samples to aid in early breast cancer detection. Sindy holds a Master's degree in Biotechnology and a Bachelor's degree in Biology, both from the University of San Francisco.
This person is not in the org chart
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.